Diagnosis and Staging of Metabolic Dysfunction-Associated Steatotic Liver Disease Using Biomarker-Directed Aptamer Panels

Diagnosis and Staging of Metabolic Dysfunction-Associated Steatotic Liver Disease Using Biomarker-Directed Aptamer Panels

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects one-third of adults globally. Despite efforts to develop non-invasive diagnostic tools, liver biopsy remains the gold standard for diagnosing metabolic dysfunction-associated steatohepatitis (MASH) and assessing fibrosis. This...

Full description

Bibliographic Details
Main Authors: Mikkel B. Kjær, Asger G. Jørgensen, Søren Fjelstrup, Daniel M. Dupont, Claus Bus, Peter L. Eriksen, Karen L. Thomsen, Jeyanthini Risikesan, Søren Nielsen, Charlotte W. Wernberg, Mette M. Lauridsen, Elisabetta Bugianesi, Chiara Rosso, Henning Grønbæk, Jørgen Kjems
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Biomolecules
Subjects:
biomarker
aptamer
metabolic dysfunction-associated steatotic liver disease
metabolic dysfunction-associated steatohepatitis
Online Access:https://www.mdpi.com/2218-273X/15/2/255

Internet

https://www.mdpi.com/2218-273X/15/2/255

Similar Items